Telomere Length and Survival in Patients with Locally Advanced UnresectableNon-small Cell Lung Cancer (NSCLC): Is There a Relationship?
Alfredo Marín Muñiz, Olivia Jordi-Ollero, Beatriz Fernández-Varas, Mónica Arellano-Vengoechea et autres
Introduction: Telomerase is overexpressed in 80% of tumors, preventing telomere shortening and providing cellular immortality. Immunotherapy (IT) after concurrent chemoradiotherapy (CCRT) has a benefit in overall survival (OS) in patients with NSCLC PDL-1 positive. Objective: to analyze the relationship between telomere length …
es (code pays fourni par la source)